• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分析鳞状细胞癌的遗传特征和功能蛋白质组学:分子分类建议。

Genetic Profile and Functional Proteomics of Anal Squamous Cell Carcinoma: Proposal for a Molecular Classification.

机构信息

Biomedica Molecular Medicine SL, C/ Faraday 7, 28049, Madrid, Spain.

Medical Oncology Department, Hospital Universitario La Paz, Paseo de la Castellana 261, 28046, Madrid, Spain.

出版信息

Mol Cell Proteomics. 2020 Apr;19(4):690-700. doi: 10.1074/mcp.RA120.001954. Epub 2020 Feb 27.

DOI:10.1074/mcp.RA120.001954
PMID:32107283
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7124473/
Abstract

Anal squamous cell carcinoma is a rare tumor. Chemo-radiotherapy yields a 50% 3-year relapse-free survival rate in advanced anal cancer, so improved predictive markers and therapeutic options are needed. High-throughput proteomics and whole-exome sequencing were performed in 46 paraffin samples from anal squamous cell carcinoma patients. Hierarchical clustering was used to establish groups Then, probabilistic graphical models were used to study the differences between groups of patients at the biological process level. A molecular classification into two groups of patients was established, one group with increased expression of proteins related to adhesion, T lymphocytes and glycolysis; and the other group with increased expression of proteins related to translation and ribosomes. The functional analysis by the probabilistic graphical model showed that these two groups presented differences in metabolism, mitochondria, translation, splicing and adhesion processes. Additionally, these groups showed different frequencies of genetic variants in some genes, such as and Finally, genetic and proteomic characteristics of these groups suggested the use of some possible targeted therapies, such as PARP inhibitors or immunotherapy.

摘要

分析鳞状细胞癌是一种罕见的肿瘤。在晚期肛门癌中,化疗放疗可使 3 年无复发生存率达到 50%,因此需要改进预测标志物和治疗选择。对 46 例肛门鳞状细胞癌患者的石蜡样本进行了高通量蛋白质组学和全外显子测序。采用层次聚类建立组群,然后采用概率图模型研究患者组之间在生物学过程水平上的差异。建立了一种分子分类方法,将一组患者的蛋白表达水平上调,与黏附、T 淋巴细胞和糖酵解有关;另一组患者的蛋白表达水平上调,与翻译和核糖体有关。概率图模型的功能分析表明,这两组在代谢、线粒体、翻译、剪接和黏附过程中存在差异。此外,这些组在一些基因(如 和 )中显示出不同的遗传变异频率。最后,这些组的遗传和蛋白质组学特征表明可能使用一些靶向治疗方法,如 PARP 抑制剂或免疫疗法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bca/7124473/5f4c4d79b6a4/zjw0042061110008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bca/7124473/5f4c4d79b6a4/zjw0042061110008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bca/7124473/5f4c4d79b6a4/zjw0042061110008.jpg

相似文献

1
Genetic Profile and Functional Proteomics of Anal Squamous Cell Carcinoma: Proposal for a Molecular Classification.分析鳞状细胞癌的遗传特征和功能蛋白质组学:分子分类建议。
Mol Cell Proteomics. 2020 Apr;19(4):690-700. doi: 10.1074/mcp.RA120.001954. Epub 2020 Feb 27.
2
Proteomic signatures reveal a dualistic and clinically relevant classification of anal canal carcinoma.蛋白质组学特征揭示了肛门管癌的双重且具有临床相关性的分类。
J Pathol. 2017 Mar;241(4):522-533. doi: 10.1002/path.4858. Epub 2017 Jan 27.
3
Utility of CYP2D6 copy number variants as prognostic biomarker in localized anal squamous cell carcinoma.CYP2D6 拷贝数变异作为局部肛门鳞癌预后生物标志物的效用。
Cancer. 2023 Aug 15;129(16):2581-2592. doi: 10.1002/cncr.34797. Epub 2023 Apr 25.
4
Comprehensive Genomic Profiling of Metastatic Squamous Cell Carcinoma of the Anal Canal.肛门转移性鳞状细胞癌的全面基因组分析。
Mol Cancer Res. 2017 Nov;15(11):1542-1550. doi: 10.1158/1541-7786.MCR-17-0060. Epub 2017 Aug 7.
5
Epidermal growth factor receptor and K-RAS status in two cohorts of squamous cell carcinomas.表皮生长因子受体和 K-RAS 状态在两个鳞状细胞癌队列中。
BMC Cancer. 2010 May 11;10:189. doi: 10.1186/1471-2407-10-189.
6
Molecular biology of anal squamous cell carcinoma: implications for future research and clinical intervention.肛门鳞癌的分子生物学:对未来研究和临床干预的启示。
Lancet Oncol. 2015 Dec;16(16):e611-21. doi: 10.1016/S1470-2045(15)00292-2.
7
Tumor-infiltrating CD8(+) T lymphocytes associated with clinical outcome in anal squamous cell carcinoma.与肛管鳞状细胞癌临床结局相关的肿瘤浸润性CD8(+) T淋巴细胞
J Surg Oncol. 2015 Sep;112(4):421-6. doi: 10.1002/jso.23998. Epub 2015 Aug 19.
8
Comprehensive genomic profiling of anal squamous cell carcinoma reveals distinct genomically defined classes.肛门鳞状细胞癌的全面基因组分析揭示了具有明显基因组定义特征的不同类别。
Ann Oncol. 2016 Jul;27(7):1336-41. doi: 10.1093/annonc/mdw152. Epub 2016 Apr 6.
9
Description of the genetic variants identified in a cohort of patients diagnosed with localized anal squamous cell carcinoma and treated with panitumumab.描述在接受帕尼单抗治疗的局部肛门鳞癌患者队列中鉴定的遗传变异体。
Sci Rep. 2021 Apr 1;11(1):7402. doi: 10.1038/s41598-021-86966-w.
10
Squamous cell carcinoma antigen: a potentially useful prognostic marker in squamous cell carcinoma of the anal canal and margin.鳞状细胞癌抗原:肛管和边缘鳞状细胞癌中具有潜在应用价值的预后标志物。
Cancer. 2013 Jul 1;119(13):2391-8. doi: 10.1002/cncr.28055. Epub 2013 Apr 10.

引用本文的文献

1
Unraveling Emerging Anal Cancer Clinical Biomarkers from Current Immuno-Oncogenomics Advances.从当前免疫肿瘤基因组学进展中解析新兴的肛管癌临床生物标志物
Mol Diagn Ther. 2024 Mar;28(2):201-214. doi: 10.1007/s40291-023-00692-9. Epub 2024 Jan 24.
2
Client Applications and Server-Side Docker for Management of RNASeq and/or VariantSeq Workflows and Pipelines of the GPRO Suite.客户端应用程序和服务器端 Docker 用于管理 GPRO 套件的 RNASeq 和/或 VariantSeq 工作流程和管道。
Genes (Basel). 2023 Jan 19;14(2):267. doi: 10.3390/genes14020267.
3
Low level of Fibrillarin, a ribosome biogenesis factor, is a new independent marker of poor outcome in breast cancer.

本文引用的文献

1
MYH9 Promotes Growth and Metastasis via Activation of MAPK/AKT Signaling in Colorectal Cancer.MYH9通过激活丝裂原活化蛋白激酶/蛋白激酶B信号通路促进结直肠癌的生长和转移。
J Cancer. 2019 Jan 29;10(4):874-884. doi: 10.7150/jca.27635. eCollection 2019.
2
Histone deacetylase inhibitors suppress aggressiveness of head and neck squamous cell carcinoma via histone acetylation-independent blockade of the EGFR-Arf1 axis.组蛋白去乙酰化酶抑制剂通过非组蛋白乙酰化依赖性阻断 EGFR-Arf1 轴抑制头颈部鳞状细胞癌的侵袭性。
J Exp Clin Cancer Res. 2019 Feb 18;38(1):84. doi: 10.1186/s13046-019-1080-8.
3
Higher autocrine motility factor/glucose-6-phosphate isomerase expression is associated with tumorigenesis and poorer prognosis in gastric cancer.
Fibrillarin 水平低,一种核糖体生物发生因子,是乳腺癌不良预后的一个新的独立标志物。
BMC Cancer. 2022 May 11;22(1):526. doi: 10.1186/s12885-022-09552-x.
较高的自分泌运动因子/葡萄糖-6-磷酸异构酶表达与胃癌的肿瘤发生及较差预后相关。
Cancer Manag Res. 2018 Oct 25;10:4969-4980. doi: 10.2147/CMAR.S177441. eCollection 2018.
4
Anal Carcinoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.肛门癌临床实践指南 2018 年版 NCCN 肿瘤学
J Natl Compr Canc Netw. 2018 Jul;16(7):852-871. doi: 10.6004/jnccn.2018.0060.
5
Epithelial membrane protein 1 promotes tumor metastasis by enhancing cell migration via copine-III and Rac1.上皮膜蛋白 1 通过增强细胞迁移来促进肿瘤转移,这是通过 copine-III 和 Rac1 实现的。
Oncogene. 2018 Oct;37(40):5416-5434. doi: 10.1038/s41388-018-0286-0. Epub 2018 Jun 4.
6
Over-expression of IQGAP1 indicates poor prognosis in head and neck squamous cell carcinoma.IQGAP1 的过表达预示着头颈鳞状细胞癌预后不良。
J Mol Histol. 2018 Aug;49(4):389-398. doi: 10.1007/s10735-018-9779-y. Epub 2018 May 30.
7
BoxCar acquisition method enables single-shot proteomics at a depth of 10,000 proteins in 100 minutes.盒车采集方法可实现单次蛋白质组学分析,在 100 分钟内检测 10000 种蛋白质。
Nat Methods. 2018 Jun;15(6):440-448. doi: 10.1038/s41592-018-0003-5. Epub 2018 May 7.
8
Molecular characterization of breast cancer cell response to metabolic drugs.乳腺癌细胞对代谢药物反应的分子特征
Oncotarget. 2018 Jan 8;9(11):9645-9660. doi: 10.18632/oncotarget.24047. eCollection 2018 Feb 9.
9
Exome sequencing reveals aberrant signalling pathways as hallmark of treatment-naive anal squamous cell carcinoma.外显子组测序揭示异常信号通路是未经治疗的肛管鳞状细胞癌的标志。
Oncotarget. 2017 Dec 8;9(1):464-476. doi: 10.18632/oncotarget.23066. eCollection 2018 Jan 2.
10
Cancer statistics, 2018.癌症统计数据,2018 年。
CA Cancer J Clin. 2018 Jan;68(1):7-30. doi: 10.3322/caac.21442. Epub 2018 Jan 4.